ProBiotix Health launches new innovative InstaMelt formulation to support cardiometabolic health at Vitafoods Europe
ProBiotix Health Plc (‘ProBiotix’), a life sciences company that develops finished probiotic formulations to support cardiometabolic health, has launched InstaMelt – a newly developed food supplement that offers innovative features for health brands and retailers to rebrand as a full turn-key solution.
Featuring two science-backed and natural ingredients, the InstaMelt formulation contains the company’s proprietary ingredient LPLDL®, a patented probiotic strain with proven efficacy from multiple independent human intervention studies to significantly decrease LDL and increase HDL cholesterol levels, and Thiamine (Vitamin B1), which supports heart function.
The life sciences company previously teased the InstaMelt technology at SupplySide West – one of the largest tradeshows in the US – with visitors at its exhibition stand. Now it’s launching the solution at Vitafoods Europe at stand P56, where visitors will be able to taste InstaMelt between 14-16th May, along with the company’s full product range available to view.
Niels Peter Bak, Head of Product Management at ProBiotix, commented: “Our InstaMelt formulation was an instant hit at SupplySide West last year and we are pleased to formally launch it for health brands and retailers to add to their own range. Many visitors to our exhibition stand remarked on how easy it dissolves on the tongue, while delivering a pleasant mouthfeel.
“The product uses InstaMelt technology, a unique dosing technology to help health brands deliver the patented strain in a novel and convenient way. Its superior organoleptic properties, combined with natural fruit flavours, make the InstaMelt formulation a great addition to any heart health and wellness portfolio.”
Available in redberry and peach flavours at launch, the InstaMelt formulation is conveniently designed to be taken once daily after a main meal in a laser cut foil which is easy to tear open.
In addition, the vegan, allergen-and-GMO-free stick pack can also claim under EFSA rulings that it contributes to the normal function of the heart1. Under structure function claims in the US, InstaMelt helps maintain cholesterol levels already in the normal range, supports normal LDL and HDL cholesterol levels, has a positive effect on cholesterol levels within the normal range, and benefits long-term cardiovascular health*.
“The InstaMelt formulation is a complementary product offered within our range of cardiometabolic health finished dosage format supplements at ProBiotix. With more flavours available in the near future, formulators can rest assured that they are choosing innovative and patented ingredients that deliver a safe and natural solution with scientifically validated efficacy in lowering cholesterol and supporting overall cardiometabolic health,” continued Niels.
LPLDL® has been used in multiple studies2,3 to demonstrate its efficacy to support cardiometabolic health. Results have shown that the solution can reduce multiple cardiometabolic biomarkers, delivering a reduction in total cholesterol by 34%, LDL cholesterol by 28%, non-HDL cholesterol by 17% and ApoB by 28%. LPLDL® has also been shown to be safe with no observed side effects.
Discover the innovative InstaMelt technology and explore the pioneering LPLDL® studies that underscore ProBiotix’s commitment to advancing cardiometabolic health at probiotixhealth.com.
References
1. EFSA Journal (2009). 7(9):1222
2. Costabile A et al., (2017). https://doi.org/10.1371/journal.pone.0187964
3. Keleszade E et al., (2022). JFF, 89: 104939
*These statements have not been evaluated by the Food and Drug Administration.
This product is not intended to diagnose, treat, cure, or prevent any disease.
